Plain-English translation of NCT06146816 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing infrared light therapy — a safe, heat-based light treatment — to see if it can help reduce Crohn's disease symptoms and inflammation. Researchers are exploring whether this simple treatment might help patients who haven't responded well to standard medications or want additional options alongside their current care.
Many people with Crohn's disease don't respond well to standard immune-suppressing medications, and some experience serious side effects. This trial explores whether infrared light therapy could offer a gentler, safer alternative or additional tool to help manage the disease.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll receive 10 sessions of infrared light therapy (or placebo) at the study clinic, with each session lasting 30 minutes. During treatment, a trained staff member will apply warm infrared light to your abdomen, focusing more time on the area where your intestine is most inflamed. If you respond well after 10 sessions, you may have the option to receive 10 additional treatments.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Israel
Sponsor
Shmuel Kivity, MD
Enrollment target
~40 participants
Started
September 2023
Primary completion
September 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nitsan Maharshak, Professor
Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.